Royal Bank of Canada’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 6631 |
|
2025
Q1 | $0 | Sell |
13
-2
| -13% | – | ﹤0.01% | 6416 |
|
2024
Q4 | $0 | Buy |
15
+10
| +200% | – | ﹤0.01% | 6388 |
|
2024
Q3 | $0 | Sell |
5
-3
| -38% | – | ﹤0.01% | 6391 |
|
2024
Q2 | $0 | Buy |
8
+4
| +100% | – | ﹤0.01% | 6643 |
|
2024
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 6551 |
|
2023
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 6573 |
|
2023
Q3 | $1K | Sell |
4
-3
| -43% | -$750 | ﹤0.01% | 6368 |
|
2023
Q2 | $2K | Sell |
7
-29
| -81% | -$8.29K | ﹤0.01% | 6388 |
|
2023
Q1 | $24K | Sell |
36
-42
| -54% | -$28K | ﹤0.01% | 5571 |
|
2022
Q4 | $67K | Buy |
78
+68
| +680% | +$58.4K | ﹤0.01% | 5254 |
|
2022
Q3 | $11K | Buy |
10
+4
| +67% | +$4.4K | ﹤0.01% | 5883 |
|
2022
Q2 | $5K | Sell |
6
-38
| -86% | -$31.7K | ﹤0.01% | 6164 |
|
2022
Q1 | $67K | Sell |
44
-179
| -80% | -$273K | ﹤0.01% | 5417 |
|
2021
Q4 | $399K | Buy |
223
+53
| +31% | +$94.8K | ﹤0.01% | 4178 |
|
2021
Q3 | $563K | Buy |
170
+16
| +10% | +$53K | ﹤0.01% | 3777 |
|
2021
Q2 | $676K | Buy |
154
+91
| +144% | +$399K | ﹤0.01% | 3581 |
|
2021
Q1 | $308K | Buy |
63
+49
| +350% | +$240K | ﹤0.01% | 4124 |
|
2020
Q4 | $26K | Buy |
14
+1
| +8% | +$1.86K | ﹤0.01% | 5384 |
|
2020
Q3 | $5K | Buy |
13
+12
| +1,200% | +$4.62K | ﹤0.01% | 5633 |
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6130 |
|
2020
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6141 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 6195 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 5985 |
|